Team: Howard W. Bruckner, M.D.
InnovationState of the art practice expands traditional cancer treatment and management to allow for a more innovative, proven approach.
Under the leadership of Dr. Howard Bruckner, the entire staff of physicians and nurses at Bruckner Oncology extend their clinical reach within today’s leading academic and research institutions to work as partners with their patients to provide a true patient-centric focus – to find the best treatment plan for each individual patient.
Dr. Bruckner is internationally recognized for a truly groundbreaking approach to cancer treatment from the bench of his laboratory all the way to the patient to provide more than just treatment and management – but hope, as well.
ExperienceWith over 40 years of clinical and research experience, few can come close to the breadth and depth of experience of Dr. Howard Bruckner.
Not just a founder but also today’s driver in best in class cancer treatment and management, Dr. Bruckner and Bruckner Oncology take an integrative and personalized approach to cancer treatment, management and research.
Dr. Bruckner received his B.S. from Brooklyn College and M.D. from Albert Einstein College of Medicine. In addition to postdoctoral training at both Albert Einstein College of Medicine and Yale University School of Medicine, Dr. Bruckner has also held several academic appointments at the Mount Sinai School of Medicine and State University of New York (SUNY) Downstate Brooklyn NY School of Medicine.
Dr. Bruckner is a leader in his field, having held several director appointments at Mount Sinai Hospital, Lutheran Medical Center, Cabrini Medical Center, and St. Vincent’s Medical Center.
Dr. Bruckner has been a member of over 20 national professional societies and committees, a consultant and reviewer for numerous professional journals and pharmaceutical and biotechnology companies, co-authored over 150 peer reviewed reports and articles, numerous book chapter and abstracts and is an often invited speaker for various symposia and lectures.
ResultsA pioneer in treating a variety of difficult cancer types, including pancreatic cancer and ovarian cancer.
Dr. Bruckner has a passion for and unrelenting commitment to understanding, exploring and creating new ways of conquering cancer and most importantly, improving the life of his patients and their families.
Dr. Bruckner has pioneered the field of designing new low dose chemotherapy regimens to treat a variety of tumors that are difficult, more resistant to traditional treatments and specific to particular diseases.
Dr. Bruckner is among the first and most successful practitioners to demonstrate the ability to shrink cancers thereby allowing for better chance of success for both radiation therapy and surgery to eliminate tumors that had previously been thought to be inoperable.